Cremer J, Karck M, Ahnsel T, Steinhoff G, Brandt M, Hollander D, Teebken O, Zick G, Haverich A
Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Germany.
Thorac Cardiovasc Surg. 1998 Sep;46 Suppl 2:298-301. doi: 10.1055/s-2007-1013089.
Experimental preconditioning is commonly regarded as a powerful protective phenomenon in case of subsequent ischemia. However, little is known about the applicability of preconditioning as an adjunct to cardioplegic myocardial protection in routine coronary surgery. For this reason, a prospective clinical study (611995 to 4/1996) was initiated to evaluate normothermic ischemic preconditioning prior to crystalloid or cold blood cardioplegic arrest. Preconditioning was performed in two cycles of 5 min ischemia and 10 min reperfusion. Four groups of 7 patients each were compared regarding release of troponin T, creatine kinase-myocardial isoform (CK-MB), lactate, and total CK in coronary sinus effluents over a 12-hour period. In the absence of perioperative myocardial infarction, there were no significant differences in these ischemic and metabolic parameters. Unexpectedly, the heed of postoperative pharmacological inotropic support was greater after preconditioning. These results may indicate that ischemic preconditioning as an adjunct to cardioplegic arrest may be associated with impairment of left-ventricular contractility, thus even exerting potentially detrimental functional effects. Overall, the proven beneficial effects of experimental preconditioning seem not to be directly transferable into the clinical settings.
实验性预处理通常被视为在随后发生缺血时的一种强大的保护现象。然而,关于预处理作为常规冠状动脉手术中心肌麻痹心肌保护辅助手段的适用性,人们了解甚少。因此,开展了一项前瞻性临床研究(1995年6月至1996年4月),以评估在晶体或冷血心脏停搏前进行常温缺血预处理的效果。预处理以两个5分钟缺血和10分钟再灌注的周期进行。比较了四组患者(每组7例)在12小时内冠状窦流出液中肌钙蛋白T、肌酸激酶心肌同工酶(CK-MB)、乳酸和总CK的释放情况。在没有围手术期心肌梗死的情况下,这些缺血和代谢参数没有显著差异。出乎意料的是,预处理后术后药物性正性肌力支持的需求更大。这些结果可能表明,作为心脏停搏辅助手段的缺血预处理可能与左心室收缩力受损有关,从而甚至可能产生潜在的有害功能影响。总体而言,实验性预处理已证实的有益效果似乎无法直接应用于临床环境。